Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
By reconstructing ancient nitrogen-processing enzymes, scientists are uncovering new clues about how early life survived on a very different Earth.
Cayman advanced the protocol from a 1-L setup to a 100-L pilot run, operating the reaction and analysis independently.
When a virus infects a bacterial cell, the viral genome is the first component to be fully injected into the cell, making it an ideal immune target. A bacterial enzyme anchored to the membrane ...
Scientists recorded 24 hours of the cellular construction process, revealing surprising new details about how plant cell ...
Morning Overview on MSN
Engineered bacteria deliver chemo drug inside tumors in mice
Researchers at the National University of Singapore have engineered a common gut bacterium to carry a chemotherapy prodrug directly into tumors, converting it into the potent cancer-killing agent ...
Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.
A new study suggests that suppressing a cellular enzyme long considered protective against fatty liver disease could have unexpected long-term consequences.
Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential to be superior to monoclonal antibodies and restore ...
It has long been known that our bodies derive energy from sugar. Researchers at RPTU University Kaiserslautern-Landau have ...
The Iñupiat people of Alaska have long said that bowhead whales live two human lifetimes. That oral knowledge turned out to be conservative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results